Anthraquinones: Bioactive Multifaceted Therapeutic Agents

Anthraquinones are aromatic organic compounds essential in both nature and industry, known for their diverse applications. Anthraquinones with a chemical formula of C14H8O2 are commonly found in plants like Aloe vera and rhubarb, fungi, lichens (a symbiosis of fungi and algae), bacteria like Streptomyces species, and certain animals like crinoids and sponges. It has various biological functions such as antimicrobial properties and anticancer activities. Anthraquinones are synthesized through natural processes like the polyketide and shikimate pathways within plants and extracted using methods such as ultrasound-assisted extraction and super critical fluid extraction for their isolation and purification. In the medical field, anthraquinones play a crucial role in the development of drugs like anthracyclines for cancer and metformin for diabetes treatment, showcasing their therapeutic potential. Industrially, anthraquinones find application as natural dyes in textiles, imparting vibrant colors, and as additives in papermaking to enhance the strength and durability of paper products, highlighting their versatility in diverse industrial sectors. The utilization of analytical techniques such as ultraviolet-visible (UV-Vis) spectroscopy is essential for determining the absorption spectra of anthraquinones, while high-performance liquid chromatography is crucial for separating and quantifying individual compounds, emphasizing their indispensable roles in accurate anthraquinone analysis. The compound's significance extends beyond its bioactivities, playing a vital role in various industrial applications, which underscores the ongoing research and interest in exploiting its properties for innovative solutions in healthcare, manufacturing, and environmental sustainability

Anthraquinones are a class of secondary metabolites, have garnered significant interest due to their diverse biological activities and various industrial applications. The derivatives of anthraquinones are widely distributed in nature, being found in numerous plants, fungi, and bacteria. The biosynthetic pathways leading to anthraquinones differ among various organisms, yet common underlying mechanisms can be observed. Enzymatic reactions play a pivotal role in the functionalization and diversification of anthraquinones. Cytochrome P450 monooxygenases, glycosyltransferases, and acyltransferases are key enzymes involved in modifying the basic anthraquinone skeleton, leading to a wide array of structurally distinct derivatives. Moreover, advances in genomic and proteomic technologies have facilitated the discovery of genes and enzymes responsible for anthraquinone biosynthesis. Genetic engineering and synthetic biology approaches have enabled the manipulation of biosynthetic pathways, paving the way for the production of novel anthraquinones with engineering and synthetic biology approaches have enabled the manipulation of biosynthetic pathways, paving the way for the production of novel anthraquinones with enhanced bioactivity and potential applications in pharmaceuticals, agrochemicals, and the dye industry. In the present work, we will focus on the different biosynthetic pathways for the biosynthesis of anthraquinones.

Anthraquinones are organic compounds and members of the Quinone family comprising 9, 10-anthracenedione core. Anthraquinone is a chemical scaffold that has been employed for many years in a variety of therapeutic applications such as antimicrobial, anticancer, diuretic, anti-inflammatory, and phytoestrogen activities. Anthraquinones are commonly produced as secondary metabolites in various higher plant species (senna, buckthorn, yellow dock) or they can either be synthesized using chemical routes such as the condensation of 1, 4-naphthoquinone with butadiene, naphthalene oxidation, anthracene oxidation, etc. Anthraquinones are used in various traditional and ethnomedical processes for the treatment of acute as well as chronic illness and are nowadays employed in modern pharmaceutical markets as a key bioactive agent. Hence, due to these properties, anthraquinone-based compounds are widely used in phytotherapy. Anthraquinones are unique in terms of their structure, chemical stability, biological properties, and industrial applications among all reported quinones, making them valuable in a wide range of drug formulations. The in-depth studies regarding the role of anthraquinones using in vitro and in vivo models need to be extensively explored for bioactive and phytotherapy applications. In addition to this, the safety and toxicity assessment need to be thoroughly investigated. The knowledge regarding its biochemical structure can pave the way to understanding its physiological and toxicological properties. The chapter dispenses compact knowledge regarding anthraquinones aspotential bioactive agents and their use as a therapeutic/health product.

Cancer is one of the high-mortality-causing diseases in the world. It causes a serious threat to mankind with an estimated 10 million deaths every year. Identifying novel drug candidates for the treatment of various types of cancer is a prime research area in medicinal chemistry. Even though many drug molecules are used in cancer treatment, they suffer from various drawbacks, such as low selectivity, toxicity, and resistance to new tumor cells. Hence, the search for novel anti-cancer agents is a continuous process in order to develop more efficient and less toxic chemotherapeutic agents. Among them, anthraquinone, a diketo derivative of anthracene, has gained much interest in the search for novel anticancer agents. Since anthraquinone is present in various natural products, it has diverse biological properties, which makes it a prominent scaffold in medicinal chemistry. Many anthraquinone classes of anticancer agents have been developed in the last decade and remain the first treatment option for cancer. The search for novel anthraquinone derivatives by the modification of the core structure or by the introduction of newer substituents to attain higher selectivity and efficacy has gained considerable interest recently. This book chapter concisely summarizes the anticancer activities of various anthraquinone derivatives reported by researchers, either derived from natural sources or synthetically prepared.

To maintain therapeutic efficacy while reducing toxicity and biocompatibility, innovative safety delivery techniques with improved nanotechnology are developed. Nanotechnology develops delivery systems that enhance the solubilizing and release quality of drugs, as well as their circulation time, which is important to enhance the therapeutic efficacy of drugs. Anthraquinones are organic substances that may be found in various plants, animals, and even some marine life. They are simple anthrones or bianthrones chemically speaking. They are used as pigments, dyes, and pharmaceuticals. Anthraquinone glycosides possess biological qualities including laxative, anti-inflammatory, anti-cancer, and antioxidants. Anthraquinones have certain drawbacks, such as their poor solubility in aqueous media, which restricts the routes of administration and lowers their bioavailability while also exhibiting a lower degree of selectivity for target tissues. It is speculated that anthraquinones and nanostructures work together. This chapter describes the application of nanotechnology in the treatment of anthraquinone-mediated diseases. The utilization of anthraquinone-loaded nanoparticles, nanocapsules, and nanocarriers in the treatment of various illnesses is highlighted.

Anthraquinone-based nanomaterials (ANMs) have recently garnered considerable attention due to their potential applications in cancer therapy. Anthraquinones are characterized by their tricyclic aromatic structure, which can be modified and incorporated into nanomaterials for various therapeutic purposes in cancer treatment. There are several ways in which ANMs are currently being investigated for cancer therapy such as improved drug delivery systems, photothermal therapy, photodynamic therapy, imaging agents (anti-cancer agents), combination therapy, and biomarker detection. It is important to highlight that ongoing research in the field of nanomedicine is continuously advancing, and the exploration of ANMs for cancer therapy is a rapidly evolving area. Recent studies reported in the literature show that ANMs effectively inhibit cancer by reactive oxygen species formation, paraptosis, autophagy, apoptosis, and various cell signaling pathways. Furthermore, before these ANMs can be extensively utilized in cancer therapy, regulatory approval and clinical trials are mandatory steps in the process. The chapter outlines a comprehensive overview of ANMs, highlighting their potential use for therapeutic, cancer therapy, and various health products.